Sharma M, Mueller J C, Zimprich A, Lichtner P, Hofer A, Leitner P, Maass S, Berg D, Dürr A, Bonifati V, De Michele G, Oostra B, Brice A, Wood N W, Muller-Myhsok B, Gasser T
Hertie-Institute for Clinical Brain Research, Department for Neurodegenerative Diseases, University of Tübingen, Hoppe-Seyler Str 3, 72076 Tübingen, Germany.
J Med Genet. 2006 Jul;43(7):557-62. doi: 10.1136/jmg.2005.039149. Epub 2006 Jan 27.
Parkinson's disease is a genetically complex disease with mixed mode of inheritance. Recently, a haplotype across the sepiapterin reductase (SPR) gene, which is located in the PARK3 linkage region, was shown to modulate age of onset of Parkinson's disease in sibships from North America.
To make a thorough assessment of the SPR gene region in sporadic Parkinson's disease.
A linkage study in 122 European sibship families with five microsatellite and 17 single nucleotide polymorphism (SNP) markers in and around the SPR gene region, and an association analysis in 340 sporadic cases of Parkinson's disease and 680 control subjects from Germany with 40 SNPs. Linkage was evaluated by non-parametric linkage scores and genotypic or haplotype association was tested by regression analysis, assuming different risk effect models.
Significant LOD scores between 2 and 3 were obtained at the two SPR-flanking markers D2S2110 and D2S1394 and seven SNP markers around the SPR gene. We found the previously reported promoter SNP rs1876487 also significantly associated with age of onset in our sib pair families (p-value 0.02). One strong linkage disequilibrium (LD) block of 45 kb including the entire SPR gene was observed. Within this LD block all 14 inter-correlated SNPs were significantly associated with Parkinson's disease affection status (p-value 0.004).
DNA polymorphisms in a highly intercorrelated LD block, which includes the SPR gene, appear to be associated with both sporadic and familial Parkinson's disease. This confirms a previous study showing that SPR potentially modulates the onset of or risk for Parkinson's disease.
帕金森病是一种具有复杂遗传模式的遗传性疾病。最近,位于PARK3连锁区域的蝶呤还原酶(SPR)基因上的一个单倍型被证明可调节北美同胞家族中帕金森病的发病年龄。
全面评估散发性帕金森病患者的SPR基因区域。
对122个欧洲同胞家族进行连锁研究,使用SPR基因区域内及周边的5个微卫星标记和17个单核苷酸多态性(SNP)标记;对340例德国散发性帕金森病患者和680例对照者进行关联分析,使用40个SNP标记。通过非参数连锁分数评估连锁情况,采用回归分析检验基因型或单倍型关联,假设不同的风险效应模型。
在SPR基因两侧的标记D2S2110和D2S1394以及SPR基因周围的7个SNP标记处获得了2至3之间的显著LOD分数。我们发现先前报道的启动子SNP rs1876487在我们的同胞对家族中也与发病年龄显著相关(p值为0.02)。观察到一个包含整个SPR基因的45 kb的强连锁不平衡(LD)区域。在这个LD区域内,所有14个相互关联的SNP均与帕金森病患病状态显著相关(p值为0.004)。
一个高度相互关联的LD区域(包括SPR基因)中的DNA多态性似乎与散发性和家族性帕金森病均相关。这证实了先前的一项研究,表明SPR可能调节帕金森病的发病或风险。